These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 1752781

  • 1. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL, Shirai T, Kato T, Asamoto M, Fukushima S.
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [Abstract] [Full Text] [Related]

  • 2. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T, Shirai T, Takahashi S, Mutai M, Fukushima S.
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [Abstract] [Full Text] [Related]

  • 3. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.
    Imaida K, Fukushima S, Shirai T, Ohtani M, Nakanishi K, Ito N.
    Carcinogenesis; 1983 Nov; 4(7):895-9. PubMed ID: 6135514
    [Abstract] [Full Text] [Related]

  • 4. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Fukushima S, Ogiso T, Kurata Y, Hirose M, Ito N.
    Cancer Lett; 1987 Jan; 34(1):83-90. PubMed ID: 3802071
    [Abstract] [Full Text] [Related]

  • 5. Differences in cell proliferation and apoptosis between reversible and irreversible mucosal lesions associated with uracil-induced urolithiasis in N-butyl-N-(4-hydroxybutyl)nitrosamine-pretreated.
    Shirai T, Shibata M, Takahashi S, Tagawa Y, Imaida K, Hirose M.
    Carcinogenesis; 1995 Mar; 16(3):501-5. PubMed ID: 7697805
    [Abstract] [Full Text] [Related]

  • 6. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Fukushima S, Kurata Y, Shibata M, Ikawa E, Ito N.
    Cancer Lett; 1984 May; 23(1):29-37. PubMed ID: 6744233
    [Abstract] [Full Text] [Related]

  • 7. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Miyata Y, Fukushima S, Hirose M, Masui T, Ito N.
    Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
    [Abstract] [Full Text] [Related]

  • 8. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
    Ito N, Fukushima S, Shirai T, Hagiwara A, Imaida K.
    IARC Sci Publ; 1984 Sep; (56):399-407. PubMed ID: 6536604
    [Abstract] [Full Text] [Related]

  • 9. Effects of uracil calculi on cell growth and apoptosis in the BBN-initiated Wistar rat urinary bladder mucosa.
    Vieira de Oliveira S, Viana de Camargo JL, Cardoso PR, Padovani CR, Fukushima S.
    Teratog Carcinog Mutagen; 1999 Sep; 19(4):293-303. PubMed ID: 10406893
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI, Wanibuchi H, Morimura K, Kim S, Yano Y, Yamamoto S, Fukushima S.
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [Abstract] [Full Text] [Related]

  • 11. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A, Tamano S, Ogiso T, Asakawa E, Fukushima S.
    Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
    [Abstract] [Full Text] [Related]

  • 12. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
    Chen TX, Wanibuchi H, Murai T, Kitano M, Yamamoto S, Fukushima S.
    Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
    [Abstract] [Full Text] [Related]

  • 13. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y, Konishi N, Shimoyama T, Hiasa Y.
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [Abstract] [Full Text] [Related]

  • 14. Absence of promoting potential of bracken fern (Pteridium aquilinum) in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and uracil.
    de Oliveira ML, Souza Rocha N, Fukushima S, de Camargo JL.
    Teratog Carcinog Mutagen; 1995 Sep; 15(4):191-9. PubMed ID: 8838633
    [Abstract] [Full Text] [Related]

  • 15. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
    Okumura M, Shirai T, Asamoto M, Ogiso T, Fukushima S.
    Cancer Lett; 1991 Jun 14; 58(1-2):81-5. PubMed ID: 2049787
    [Abstract] [Full Text] [Related]

  • 16. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T, Na Y, Wanibuchi H, Yamamoto S, Lee CC, Fukushima S.
    Jpn J Cancer Res; 1999 Aug 14; 90(8):818-23. PubMed ID: 10543252
    [Abstract] [Full Text] [Related]

  • 17. Lack of promotion of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in mice by rat cancer promoters.
    Tamano S, Asakawa E, Boomyaphiphat P, Masui T, Fukushima S.
    Teratog Carcinog Mutagen; 1993 Aug 14; 13(2):89-96. PubMed ID: 8102212
    [Abstract] [Full Text] [Related]

  • 18. Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder.
    Inoue T, Imaida K, Suzuki E, Okada M, Fukushima S.
    Cancer Lett; 1988 Jun 30; 40(3):265-73. PubMed ID: 3383181
    [Abstract] [Full Text] [Related]

  • 19. L-ascorbic acid amplification of bladder carcinogenesis promotion by K2CO3.
    Fukushima S, Kurata Y, Hasegawa R, Asamoto M, Shibata MA, Tamano S.
    Cancer Res; 1991 May 15; 51(10):2548-51. PubMed ID: 2021935
    [Abstract] [Full Text] [Related]

  • 20. Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine.
    Fukushima S, Hagiwara A, Ogiso T, Shibata M, Ito N.
    Food Chem Toxicol; 1983 Feb 15; 21(1):59-68. PubMed ID: 6681793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.